Relationship Among Genotype, Biochemical Phenotype, and Cognitive Performance in Females With Phenylalanine Hydroxylase Deficiency: Report From the Maternal Phenylketonuria Collaborative Study
- 1 August 1999
- journal article
- Published by American Academy of Pediatrics (AAP)
- Vol. 104 (2) , 258-262
- https://doi.org/10.1542/peds.104.2.258
Abstract
Objective.: To examine the relationship of phenylalanine hydroxylase (PAH) genotypes to biochemical phenotype and cognitive development in maternal phenylketonuria (PKU). Methodology.: PAH gene mutations were examined in 222 hyperphenylalaninemic females enrolled in the Maternal PKU Collaborative Study (MPKUCS). A total of 84 different mutations were detected, and complete genotype was obtained in 199 individuals. Based on previous knowledge about mutation–phenotype associations, 78 of the mutations could be assigned to one of four classes of severity (severe PKU, moderate PKU, mild PKU, and mild hyperphenylalaninemia [MHP]). Then, 189 MPKUCS subjects were grouped according to the various combinations of mutation classifications. The sample sizes were large enough for statistical testing in four groups with at least one mutation that completely abolishes enzyme activity. These patients are considered functionally hemizygous. Results.: The biochemical phenotype predicted from the genotype in functionally hemizygous patients was related significantly to the assigned phenylalanine level. Cognitive performance (IQ) was also significantly related to genotype. The IQ of PAH-deficient mothers with a severe PKU mutation in combination with a MHP mutation or a mild PKU mutation was 99 and 96, respectively, whereas the IQ of PKU mothers with two severe PKU mutations or with one severe and one moderate PKU mutation was 83 and 84, respectively. Of the patients with PKU, 92% had been treated during childhood. Those who were untreated or treated late had lower than average IQ scores for their group of mutation combinations. Females with moderate or mild PKU who were treated early and treated for >6 years showed IQ scores 10 points above average for their group. Conclusions.: The reproductive outcome in maternal phenylketonuria is dependent on prenatal metabolic control and postnatal environmental circumstances. Both factors depend on the intellectual resources of the mother with PKU. The significant relationship among genotype, biochemical phenotype, and cognitive performance observed in the present study is of importance for the development of an optimal strategy for future treatment of females with PKU who plan pregnancy.Keywords
This publication has 18 references indexed in Scilit:
- A European Multicenter Study of Phenylalanine Hydroxylase Deficiency: Classification of 105 Mutations and a General System for Genotype-Based Prediction of Metabolic PhenotypeAmerican Journal of Human Genetics, 1998
- Use of the Guthrie bacterial inhibition assay to monitor blood phenylalanine for dietary treatment of phenylketonuriaScreening, 1996
- Psychosocial factors in maternal phenylketonuria: women's adherence to medical recommendations.American Journal of Public Health, 1995
- In vivo assessment of mutations in the phenylalanine hydroxylase gene by phenylalanine loading: Characterization of seven common mutationsEuropean Journal of Pediatrics, 1995
- PAH deficiency in Italy: correlation of genotype with phenotype in the Sicilian populationJournal of Inherited Metabolic Disease, 1995
- Genotype-phenotype correlations in phenylketonuriaClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- Comparison of genotype and intellectual phenotype in untreated PKU patients.Journal of Medical Genetics, 1993
- Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patientsEuropean Journal of Pediatrics, 1993
- Molecular Basis of Phenotypic Heterogeneity in PhenylketonuriaNew England Journal of Medicine, 1991
- Cognitive development in offspring of untreated and preconceptionally treated maternal phenylketonuriaJournal of Inherited Metabolic Disease, 1990